Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Update of the NSABP STAR trial: preventing breast cancer

MBCC 12

16 - 18 Jun 2010

Published: 3 Sep 2010

Views: 8339

Rating:

Save

Dr Leslie Ford - National Cancer Institute, Bethesda, USA

Dr Leslie Ford of the Prevention National Cancer Institute, Bethesda, USA, speaking at the 12th Milan Breast Cancer Conference, June 2010. Update of the NSABP STAR trial: preventing breast cancer. Download the slides here.

Related Videos

Tackling breast cancer screening in conservative communities

Dr Ru'a Rimawi - Dana-Farber Cancer Institute, Boston, United States of America

Tackling breast cancer screening in conservative communities ( Dr Ru'a Rimawi - Dana-Farber Cancer Institute, Boston, United States of America )

Post-diagnosis diet, nutrition and cancer prognosis

Dr Doris Chan - Imperial College London, London, UK

Post-diagnosis diet, nutrition and cancer prognosis ( Dr Doris Chan - Imperial College London, London, UK )

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2...

Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies ( Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA )

Genomic testing: Awareness and effective communication between healthcare...

Prof Richard Simcock and Antonella Cardone

Genomic testing: Awareness and effective communication between healthcare professionals and patients ( Prof Richard Simcock and Antonella Cardone )

Community-based breast cancer control programme in the Philipines

Kara Magsanoc-Alikpala - ICanServe Foundation, Manila, Philippines

Community-based breast cancer control programme in the Philipines ( Kara Magsanoc-Alikpala - ICanServe Foundation, Manila, Philippines )

Initiatives for cancer control in Indonesia

Dr K Kardinah - National Cancer Center/Dharmais Cancer Hospital, Jakarta...

Initiatives for cancer control in Indonesia ( Dr K Kardinah - National Cancer Center/Dharmais Cancer Hospital, Jakarta, Indonesia )

PHERGain trial ID's early breast cancer cases that benefit from dual HER2...

Dr Javier Cortes - Vall d’Hebron University Hospital, Barcelona, Spain

PHERGain trial ID's early breast cancer cases that benefit from dual HER2 blockade without chemo ( Dr Javier Cortes - Vall d’Hebron University Hospital, Barcelona, Spain )

Genetic profiling identifies patients who can omit radiation therapy after...

Prof Per Karlsson - Sahlgrenska Comprehensive Cancer Centre, Gothenburg, Sweden

Genetic profiling identifies patients who can omit radiation therapy after breast-conserving surgery ( Prof Per Karlsson - Sahlgrenska Comprehensive Cancer Centre, Gothenburg, Sweden )

Long-term breast cancer risk after benign breast disease in population-based...

Dr Marta Roman - Hospital del Mar Medical Research Institute, Barcelona, Spain

Long-term breast cancer risk after benign breast disease in population-based screening ( Dr Marta Roman - Hospital del Mar Medical Research Institute, Barcelona, Spain )

More from ecancer